Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1995 Apr;146(4):833–847.

IGF2 expression is a marker for paraganglionic/SIF cell differentiation in neuroblastoma.

F Hedborg 1, R Ohlsson 1, B Sandstedt 1, L Grimelius 1, J C Hoehner 1, S Pählman 1
PMCID: PMC1869246  PMID: 7717451

Abstract

Neuroblastoma is a childhood tumor of the sympathetic nervous system. Observations in the Beckwith-Wiedemann syndrome suggest that sympathetic embryonal cells with an abundant expression of the insulin-like growth factor 2 gene (IGF2) may be involved in the genesis of low-malignant infant neuroblastomas. We have therefore compared the cell type-specific IGF2 expression of the human sympathetic nervous system during early development with that of neuroblastoma. An abundant expression in normal sympathetic tissue was specific to extra-adrenal chromaffin cells, ie, paraganglia and small intensely fluorescent (SIF) cells, whereas sympathetic neuronal cells were IGF2-negative. A subpopulation of neuroblastomas expressed IGF2, which correlated with an early age at diagnosis, an extra-adrenal tumor origin, and severe hemodynamic signs of catecholamine secretion. Histologically IGF2-expressing tumors displayed a lobular growth pattern, and expression was restricted to the most mature and least proliferative cells. Typically, these cells were morphologically and histochemically similar to paraganglia/SIF cells and formed distinct ring-like zones in the center of the lobules around a core of apoptosis-like tumor cells. The similarities found between IGF2-expressing neuroblastoma cells and paraganglia/SIF cells in terms of histological features, anatomical origin, and age-dependent growth suggest a paraganglionic/SIF cell lineage of most infant tumors and also of extra-adrenal tumors diagnosed after infancy. Furthermore, since paraganglia/SIF cells undergo postnatal involution, the same cellular mechanism may be responsible for spontaneous regression in infant neuroblastoma.

Full text

PDF
833

Images in this article

837Figure 2
on p.837
838Figure 3
on p.838
839p839-a
on p.839
842Figure 4
on p.842

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson D. J., Axel R. A bipotential neuroendocrine precursor whose choice of cell fate is determined by NGF and glucocorticoids. Cell. 1986 Dec 26;47(6):1079–1090. doi: 10.1016/0092-8674(86)90823-8. [DOI] [PubMed] [Google Scholar]
  2. BECKWITH J. B., PERRIN E. V. IN SITU NEUROBLASTOMAS: A CONTRIBUTION TO THE NATURAL HISTORY OF NEURAL CREST TUMORS. Am J Pathol. 1963 Dec;43:1089–1104. [PMC free article] [PubMed] [Google Scholar]
  3. Barres B. A., Hart I. K., Coles H. S., Burne J. F., Voyvodic J. T., Richardson W. D., Raff M. C. Cell death and control of cell survival in the oligodendrocyte lineage. Cell. 1992 Jul 10;70(1):31–46. doi: 10.1016/0092-8674(92)90531-g. [DOI] [PubMed] [Google Scholar]
  4. Beckwith J. B., Martin R. F. Observations on the histopathology of neuroblastomas. J Pediatr Surg. 1968 Feb;3(1):106–110. doi: 10.1016/0022-3468(68)90989-5. [DOI] [PubMed] [Google Scholar]
  5. Brodeur G. M., Pritchard J., Berthold F., Carlsen N. L., Castel V., Castelberry R. P., De Bernardi B., Evans A. E., Favrot M., Hedborg F. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993 Aug;11(8):1466–1477. doi: 10.1200/JCO.1993.11.8.1466. [DOI] [PubMed] [Google Scholar]
  6. Brundin T. Studies on the preaortal paraganglia of newborn rabbits. Acta Physiol Scand Suppl. 1966;290:1–54. [PubMed] [Google Scholar]
  7. Carlsen N. L., Christensen I. J., Schroeder H., Bro P. V., Erichsen G., Hamborg-Pedersen B., Jensen K. B., Nielsen O. H. Prognostic factors in neuroblastomas treated in Denmark from 1943 to 1980. A statistical estimate of prognosis based on 253 cases. Cancer. 1986 Dec 15;58(12):2726–2735. doi: 10.1002/1097-0142(19861215)58:12<2726::aid-cncr2820581229>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  8. Cushing H., Wolbach S. B. The Transformation of a Malignant Paravertebral Sympathicoblastoma into a Benign Ganglioneuroma. Am J Pathol. 1927 May;3(3):203–216.7. [PMC free article] [PubMed] [Google Scholar]
  9. DeChiara T. M., Efstratiadis A., Robertson E. J. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature. 1990 May 3;345(6270):78–80. doi: 10.1038/345078a0. [DOI] [PubMed] [Google Scholar]
  10. Doupe A. J., Patterson P. H., Landis S. C. Small intensely fluorescent cells in culture: role of glucocorticoids and growth factors in their development and interconversions with other neural crest derivatives. J Neurosci. 1985 Aug;5(8):2143–2160. doi: 10.1523/JNEUROSCI.05-08-02143.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. El-Badry O. M., Helman L. J., Chatten J., Steinberg S. M., Evans A. E., Israel M. A. Insulin-like growth factor II-mediated proliferation of human neuroblastoma. J Clin Invest. 1991 Feb;87(2):648–657. doi: 10.1172/JCI115042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. El-Badry O. M., Romanus J. A., Helman L. J., Cooper M. J., Rechler M. M., Israel M. A. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J Clin Invest. 1989 Sep;84(3):829–839. doi: 10.1172/JCI114243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Emery L. G., Shields M., Shah N. R., Garbes A. Neuroblastoma associated with Beckwith-Wiedemann syndrome. Cancer. 1983 Jul 1;52(1):176–179. doi: 10.1002/1097-0142(19830701)52:1<176::aid-cncr2820520132>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  14. Evans A. E., D'Angio G. J., Propert K., Anderson J., Hann H. W. Prognostic factor in neuroblastoma. Cancer. 1987 Jun 1;59(11):1853–1859. doi: 10.1002/1097-0142(19870601)59:11<1853::aid-cncr2820591102>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  15. Goldman R. L., Winterling A. N., Winterling C. C. Maturation of tumors of the sympathetic nervous system. Report of long-term survival in 2 patients, one with disseminated osseous metastases, and review of cases from the literature. Cancer. 1965 Nov;18(11):1510–1516. doi: 10.1002/1097-0142(196511)18:11<1510::aid-cncr2820181124>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  16. Haas D., Ablin A. R., Miller C., Zoger S., Matthay K. K. Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment. Cancer. 1988 Aug 15;62(4):818–825. doi: 10.1002/1097-0142(19880815)62:4<818::aid-cncr2820620430>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  17. Hayes F. A., Green A. A., Rao B. N. Clinical manifestations of ganglioneuroma. Cancer. 1989 Mar 15;63(6):1211–1214. doi: 10.1002/1097-0142(19890315)63:6<1211::aid-cncr2820630628>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  18. Hedborg F., Holmgren L., Sandstedt B., Ohlsson R. The cell type-specific IGF2 expression during early human development correlates to the pattern of overgrowth and neoplasia in the Beckwith-Wiedemann syndrome. Am J Pathol. 1994 Oct;145(4):802–817. [PMC free article] [PubMed] [Google Scholar]
  19. Hervonen A., Korkala O. The effect of hypoxia on the catecholamine content of human fetal abdominal paraganglia and adrenal medulla. Acta Obstet Gynecol Scand. 1972;51(1):17–24. doi: 10.3109/00016347209154963. [DOI] [PubMed] [Google Scholar]
  20. Joshi V. V., Cantor A. B., Altshuler G., Larkin E. W., Neill J. S., Shuster J. J., Holbrook C. T., Hayes F. A., Castleberry R. P. Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. A clinicopathologic study of 213 cases from the Pediatric Oncology Group. Cancer. 1992 Apr 15;69(8):2183–2196. doi: 10.1002/1097-0142(19920415)69:8<2183::aid-cncr2820690828>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  21. Joshi V. V., Silverman J. F., Altshuler G., Cantor A. B., Larkin E. W., Neill J. S., Norris H. T., Shuster J. J., Holbrook C. T., Hayes F. A. Systematization of primary histopathologic and fine-needle aspiration cytologic features and description of unusual histopathologic features of neuroblastic tumors: a report from the Pediatric Oncology Group. Hum Pathol. 1993 May;24(5):493–504. doi: 10.1016/0046-8177(93)90161-9. [DOI] [PubMed] [Google Scholar]
  22. Junien C. Beckwith-Wiedemann syndrome, tumourigenesis and imprinting. Curr Opin Genet Dev. 1992 Jun;2(3):431–438. doi: 10.1016/s0959-437x(05)80154-6. [DOI] [PubMed] [Google Scholar]
  23. Kogner P., Barbany G., Dominici C., Castello M. A., Raschellá G., Persson H. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res. 1993 May 1;53(9):2044–2050. [PubMed] [Google Scholar]
  24. Koistinaho J., Hatanpä K., Hervonen A. Human paraganglion cells differentiate into adrenergic neurons in culture. Exp Neurol. 1990 Mar;107(3):277–280. doi: 10.1016/0014-4886(90)90146-j. [DOI] [PubMed] [Google Scholar]
  25. Martin D. M., Feldman E. L. Regulation of insulin-like growth factor-IL expression and its role in autocrine growth of human neuroblastoma cells. J Cell Physiol. 1993 May;155(2):290–300. doi: 10.1002/jcp.1041550210. [DOI] [PubMed] [Google Scholar]
  26. Matsumoto K., Gaetano C., Daughaday W. H., Thiele C. J. Retinoic acid regulates insulin-like growth factor II expression in a neuroblastoma cell line. Endocrinology. 1992 Jun;130(6):3669–3676. doi: 10.1210/endo.130.6.1375906. [DOI] [PubMed] [Google Scholar]
  27. Matthay K. K., Sather H. N., Seeger R. C., Haase G. M., Hammond G. D. Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol. 1989 Feb;7(2):236–244. doi: 10.1200/JCO.1989.7.2.236. [DOI] [PubMed] [Google Scholar]
  28. Ohlsson R., Holmgren L., Glaser A., Szpecht A., Pfeifer-Ohlsson S. Insulin-like growth factor 2 and short-range stimulatory loops in control of human placental growth. EMBO J. 1989 Jul;8(7):1993–1999. doi: 10.1002/j.1460-2075.1989.tb03606.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ohlsson R., Nyström A., Pfeifer-Ohlsson S., Töhönen V., Hedborg F., Schofield P., Flam F., Ekström T. J. IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome. Nat Genet. 1993 May;4(1):94–97. doi: 10.1038/ng0593-94. [DOI] [PubMed] [Google Scholar]
  30. Ortoft E., Bjelfman C., Hedborg F., Grimelius L., Påhlman S. The expression profile of alternatively spliced neuronal c-src RNA distinguishes between human tumours of the sympatho-adrenal lineage. Int J Cancer. 1995 Jan 3;60(1):38–44. doi: 10.1002/ijc.2910600105. [DOI] [PubMed] [Google Scholar]
  31. Ping A. J., Reeve A. E., Law D. J., Young M. R., Boehnke M., Feinberg A. P. Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. Am J Hum Genet. 1989 May;44(5):720–723. [PMC free article] [PubMed] [Google Scholar]
  32. Påhlman S., Meyerson G., Lindgren E., Schalling M., Johansson I. Insulin-like growth factor I shifts from promoting cell division to potentiating maturation during neuronal differentiation. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):9994–9998. doi: 10.1073/pnas.88.22.9994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Påhlman S., Odelstad L., Larsson E., Grotte G., Nilsson K. Phenotypic changes of human neuroblastoma cells in culture induced by 12-O-tetradecanoyl-phorbol-13-acetate. Int J Cancer. 1981 Nov 15;28(5):583–589. doi: 10.1002/ijc.2910280509. [DOI] [PubMed] [Google Scholar]
  34. Recio-Pinto E., Rechler M. M., Ishii D. N. Effects of insulin, insulin-like growth factor-II, and nerve growth factor on neurite formation and survival in cultured sympathetic and sensory neurons. J Neurosci. 1986 May;6(5):1211–1219. doi: 10.1523/JNEUROSCI.06-05-01211.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Sandstedt B., Jereb B., Eklund G. Prognostic factors in neuroblastomas. Acta Pathol Microbiol Immunol Scand A. 1983 Sep;91(5):365–371. doi: 10.1111/j.1699-0463.1983.tb02767.x. [DOI] [PubMed] [Google Scholar]
  36. Schneid H., Vazquez M. P., Seurin D., le Bouc Y. Loss of heterozygosity in non-tumoral tissue in two children with Beckwith-Wiedemann syndrome. Growth Regul. 1991 Dec;1(4):168–170. [PubMed] [Google Scholar]
  37. Scott I. G., Akerman K. E., Heikkilä J. E., Kaila K., Andersson L. C. Development of a neural phenotype in differentiating ganglion cell-derived human neuroblastoma cells. J Cell Physiol. 1986 Aug;128(2):285–292. doi: 10.1002/jcp.1041280221. [DOI] [PubMed] [Google Scholar]
  38. Shimada H., Chatten J., Newton W. A., Jr, Sachs N., Hamoudi A. B., Chiba T., Marsden H. B., Misugi K. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst. 1984 Aug;73(2):405–416. doi: 10.1093/jnci/73.2.405. [DOI] [PubMed] [Google Scholar]
  39. Sirinelli D., Silberman B., Baudon J. J., Sinnassamy P., Gruner M., Montagne J. P. Beckwith-wiedemann syndrome and neural crest tumors. A report of two cases. Pediatr Radiol. 1989;19(4):242–245. doi: 10.1007/BF02386843. [DOI] [PubMed] [Google Scholar]
  40. WIEDEMANN H. R. COMPLEXE MALFORMATIF FAMILIAL AVEC HERNIE OMBILICALE ET MACROGLOSSIE--UN "SYNDROME NOUVEAU"? J Genet Hum. 1964 Sep;13:223–232. [PubMed] [Google Scholar]
  41. Weinblatt M. E., Heisel M. A., Siegel S. E. Hypertension in children with neurogenic tumors. Pediatrics. 1983 Jun;71(6):947–951. [PubMed] [Google Scholar]
  42. Weksberg R., Shen D. R., Fei Y. L., Song Q. L., Squire J. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nat Genet. 1993 Oct;5(2):143–150. doi: 10.1038/ng1093-143. [DOI] [PubMed] [Google Scholar]
  43. Winkler H., Fischer-Colbrie R. The chromogranins A and B: the first 25 years and future perspectives. Neuroscience. 1992 Aug;49(3):497–528. doi: 10.1016/0306-4522(92)90222-N. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES